Preserving the Academic Mission with Sonali Smith, MD (Recorded LIVE at ASCO 2025)
Oncology Overdrive
In this episode, recorded live at the 2025 ASCO annual meeting, host Shikha Jain, MD, speaks with Sonali Smith, MD, about the power of mentorship and advocacy, preserving the academic mission of research within health care systems and more. • Welcome to another exciting episode of Oncology Overdrive 1:34 • About Smith 1:56 • The interview 3:14 • What was your journey to get to where you are now in your career? 3:38 • How do you incorporate your advocacy work into patient care, and how do you advise other...
info_outline
Scientific Investment in Precision Oncology with Sadie Dobrozsi, MD
Oncology Overdrive
In this episode, host Shikha Jain, MD, speaks with Sadie Dobrozsi, MD, about the power of information in personalized oncology care, understanding the impacts of genetic testing and more. • Welcome to another exciting episode of Oncology Overdrive 1:34 • About Dobrozsi 1:39 • The interview 2:03 • What was your path to this field of pediatric oncology, and how did you decide to focus on genetic testing? 2:33 • Can you talk about what it means to use genomics to optimize therapy and tailor precision medicine, and...
info_outline
Cultural Adaptability in Global Oncology with Abiola Ibraheem, MD
Oncology Overdrive
In this episode, host Shikha Jain, MD, speaks with Abiola Ibraheem, MD, about the role culture plays in improving global oncology, launching the Best of ASCO in Africa and more. • Welcome to another exciting episode of Oncology Overdrive 1:34 • About Ibraheem 1:42 • The interview 3:02 • How did you get where you are today? 3:28 • Can you tell me more about and your role within the organization? 5:41 • What are some challenges you have encountered in doing this work, both locally and...
info_outline
Equitable Representation in Clinical Trials with Nadine Spring, PhD
Oncology Overdrive
In this episode, host Shikha Jain, MD, speaks with Nadine Spring, PhD, about the importance of DEI in clinical care, driving positive social change forward and more. • Welcome to another exciting episode of Oncology Overdrive 0:14 • About Spring 0:20 • The interview 1:00 • Tell me about the journey that got you to where you are today? 1:18 • Can you tell me more about and your role there? 5:11 • Why does diversity and equitable representation in clinical trials and care matter? 6:23 • ...
info_outline
Finding fulfillment in medicine: Physician side gigs and exploring new avenues, with Navin Goyal, MD (Crossover with Physicianary)
Oncology Overdrive
In this special crossover episode with Physicianary, guest Navin Goyal, MD, and Physicianary host, Hansa Bhargava, MD, discuss side gigs in the health care space, encourage physicians to explore their fields of interest and talk about his book, Physician Underdog. • Intro 0:28 • Navin Goyal, MD 0:35 • You have done a lot to help Medicaid patients with your venture capital group, OFFOR Health. Can you tell us about that? 1:25 • What was the driver of your venture capital group? Was it access to care? 3:21 • Tell us...
info_outline
Pioneering Changes in Patient Advocacy with Kimberly Richardson
Oncology Overdrive
In this episode, host Shikha Jain, MD, speaks with Kimberly Richardson about driving changes in patient advocacy efforts, the importance of including DEI in cancer research and clinical trials and more. • Welcome to another exciting episode of Oncology Overdrive 0:14 • About Richardson 0:20 • The interview 1:15 • How did you get to where you are today as such a leader and advocate? 1:56 • Did you feel welcomed into this space when you started doing your advocacy work, or did you feel like it was an uphill battle?...
info_outline
Survivorship and Visual Storytelling with Anna Rathkopf
Oncology Overdrive
In this episode, host Shikha Jain, MD, speaks with Anna Rathkopf about the mental and physical toll of cancer treatment and survivorship, using photography to connect with patients and caregivers and more. • Welcome to another exciting episode of Oncology Overdrive 0:14 • About Rathkopf 0:20 • The interview 1:23 • How did you get into storytelling through photography around your cancer diagnosis and your caregiver experience? 1:46 • How did you navigate questions and challenges surrounding fertility during the...
info_outline
Diversity and Development in Hematology with Belinda Avalos, MD
Oncology Overdrive
In this episode, host Shikha Jain, MD, speaks with ASH president, Belinda Avalos, MD, about the importance of DEI practices in medicine, leading molecular medicine developments and more. • Welcome to another exciting episode of Oncology Overdrive 0:14 • About Avalos 0:18 • The interview 1:18 • How did you know you know you wanted to be a hematologist and how did you end up in this space doing the work you’re doing now? 1:47 • Jain and Avalos on the innovations and patient relationships in the field of HemOnc...
info_outline
The Role of Machine Learning in Clinical Trials with Damon Rasheed
Oncology Overdrive
In this episode, host Shikha Jain, MD, speaks with Opyl co-founder Damon Rasheed about using machine learning to better predict clinical trial outcomes, handling ethical concerns surrounding AI in health care and more. • Welcome to another exciting episode of Oncology Overdrive 0:14 • About Rasheed 0:20 • The interview 0:58 • How did you end up in the AI-powered medicine and clinical trials? 1:48 • What is Opyl, and what is TrialKey? 3:54 • Is TrialKey predominantly based in Australia or is it...
info_outline
Highlights from ASH 2024 (Meeting Mic Re-Release)
Oncology Overdrive
In this special crossover episode of Oncology Overdrive, we bring you Healio coverage from the ASH Annual Meeting and Exhibition, as well as Healio’s top headlines from the meeting. Gwen L. Nichols, MD, reviews a panel discussion on how hematologists and oncologists can best address patients’ concerns as AI’s role in medicine invariably expands. :24 Thomas G. Knight, MD, addresses financial toxicity for people with blood cancer. 6:29 Charles S. Abrams, MD, discusses results of the HIBISCUS trial and its implications for vaso-occlusive events. 16:30 Read the full coverage here: ...
info_outlineIn this episode, host Shikha Jain, MD, speaks with Jonathan D. Licht, MD, about becoming and training qualified leaders in the field, challenges facing health care leaders and more.
• Welcome to another exciting episode of Oncology Overdrive :58
• About Licht 1:16
• The interview 3:17
• Can you tell us about your journey into hematology-oncology and how you ended up where you are today? 3:58
• How have you found the time and ability to balance and succeed in the research, clinical, translational and leadership parts of your work? 9:05
• What do you suggest to people who are currently trying to get into leadership positions in their early-to-mid career? 12:52
• Do you agree with the sentiment that there are some leaders in the field who are put into positions prematurely or are ineffective? As a leader, how do you address the need for further training of future leaders? 18:39
• What are some of the leadership challenges you have seen in the last several years, and how have you managed to navigate them? 23:20
• How did you use your leadership skills to navigate the first few years of the pandemic, and how are you continuing to navigate delivery of care post-pandemic? 29:23
• Tell me about the process of achieving NCI designation and what it means for your institution. 36:25
• How have you had to navigate state health care legislation and policies challenging reproductive health care? 42:16
• If someone could only listen to the last minute of this episode, what would you want them to take away? 46:13
• How to contact Licht 46:56
• Thanks for listening 48:16
Jonathan D. Licht, MD, is the director of the University of Florida Health Cancer Center.
We’d love to hear from you! Send your comments/questions to Dr. Jain at [email protected]. Follow Healio on X, formerly known as Twitter, and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/. Follow Dr. Jain on X, formerly known as Twitter: @ShikhaJainMD. Licht can be reached on X, formerly known as Twitter, @jdlicht or via email [email protected].
Disclosures: Jain reports no relevant financial disclosures. Licht reports consultancy for AstraZeneca and research funding for Epizyme.